DE518516C - Process for the preparation of basic bismuth salts of organic arsic acids - Google Patents
Process for the preparation of basic bismuth salts of organic arsic acidsInfo
- Publication number
- DE518516C DE518516C DEI36185D DEI0036185D DE518516C DE 518516 C DE518516 C DE 518516C DE I36185 D DEI36185 D DE I36185D DE I0036185 D DEI0036185 D DE I0036185D DE 518516 C DE518516 C DE 518516C
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- acids
- organic
- arsic
- bismuth salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001621 bismuth Chemical class 0.000 title claims description 9
- 238000000034 method Methods 0.000 title claims description 9
- 239000002253 acid Substances 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 7
- 150000007513 acids Chemical class 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- VJWWIRSVNSXUAC-UHFFFAOYSA-N arsinic acid Chemical class O[AsH2]=O VJWWIRSVNSXUAC-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 150000001447 alkali salts Chemical class 0.000 claims description 2
- 229910052797 bismuth Inorganic materials 0.000 claims description 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 5
- 239000003513 alkali Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- RXPAJWPEYBDXOG-UHFFFAOYSA-N hydron;methyl 4-methoxypyridine-2-carboxylate;chloride Chemical compound Cl.COC(=O)C1=CC(OC)=CC=N1 RXPAJWPEYBDXOG-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 229940074439 potassium sodium tartrate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/94—Bismuth compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Description
Verfahren zur Darstellung von basischen Wismutsalzen organischer Arsinsäuren In den Comptes Rendu.s i8o [z925], S. i 9; i . beschreibt 1. e v a d i t i ein basisches, in Alkalien lösliches Wismutsalz der 3-Acetylamino-q-oxybenzol-i-arsinsäure, das durch Umsetzung ,des Natri:umsalzes der Arsinsäure mit Bi:smutylkaliumnatrittmtartrat erhalten wird. In der englischen Patentschrift 266 82o wird ein verbessertes Verfahren zur Herstellung derartiger Salze beschrieben, das aber selber praktisch wenig .brauchbar ist, da bei seiner Durchführung verschiedene Vorsichtsmaßregeln zu beachten sind, ohne die schlechte Ausbeuten und schlecht zu isolierende Präparate erhalten werden.Process for the preparation of basic bismuth salts of organic arsinic acids In the Comptes Rendu.s i8o [z925], p. I 9; i. describes 1. e v a d i t i a basic, Bismuth salt of 3-acetylamino-q-oxybenzene-i-arsinic acid, which is soluble in alkalis by reacting the sodium salt of arsic acid with bismutyl potassium sodium tartrate is obtained. An improved method is disclosed in English patent specification 266 82o described for the production of such salts, but this itself is of little practical use is because various precautionary measures must be observed when performing it, without the poor yields and preparations that are difficult to isolate are obtained.
Es wurde.nun gefunden, .daß man auf erheblich einfachere Weise zu wismuthaltigen Arsenpräparaten, die sich vor obigen Wismutsalzen .durch ganz beträchtlich herabgesetzte Giftigkeit bei sehr guter antiparasitärer Wirkung auszeichnen, gelangen kann, wenn man die Alkalisalze organischer Arsinsäuren mit (der Lösung eines anorganischen Wis.mutsalzes umsetzt und dabei die Säureradikale des Wismutsalzes mittels Alkalis ganz abstumpft. Von der im Arch. der Pharm. 263 [i925], S. 72¢, beschriebenen Arbeitsweise unterscheidet sich vorliegendes Verfahren durch Verwendung von anorganischen Wismutsalzen und durch die angewendete Alkalimenge. Während bei dem neuen Verfahren sämtliche Säureradikale .des Wisinutsalzes abgestumpft werden, wird bei dem bekannten Verfahren eine zu diesem Zweck bei weitem nicht ausreichende Alkalimenge verwendet.It has now been found that it can be done in a considerably simpler way arsenic preparations containing bismuth, which are considerably better than the above bismuth salts characterized by reduced toxicity with a very good anti-parasitic effect can, if you combine the alkali salts of organic arsinic acids with (the solution of an inorganic Wis.mutsalzes converts and thereby the acid radicals of the bismuth salt by means of alkali quite dull. From the procedure described in Arch. Der Pharm. 263 [1925], p. 72 [ The present process differs through the use of inorganic bismuth salts and by the amount of alkali used. While in the new process all Acid radicals .des Wisinut salt are blunted, is in the known process a far insufficient amount of alkali is used for this purpose.
Die nach dem neuen Verfahren erhaltenen Präparate sind im Gegensatz zu den obenerwähnten Salzen unlöslich und eignen sich vorzüglich zur Depotbehandlung von Trvpanosomen- und Spirochätenerkrankungen. Beispiele i. 2j,5.9 3Acety:lamino-q.-oxybenzo,l-i-arsinsäure werden in ioo ccm 2n-Natronlauge gelöst. Unter starkem Rühren läßt man eine Lösung von 48,5 g Wismutnitrat in .I8,5 g Glycerin und 97.g Wasser zutropfen. Dann wird durch Zugabe von 5o ccm 2 n # Natronlauge neutralisiert, das ausgefallene Wismutsalz abgesaugt,. mit Wasser, . Alkohol und Äther gewaschen und das Produkt im Vakuum getrocknet. Das Präparat ist ein schwach gelblich gefärbtes Pulver.The preparations obtained by the new process are in contrast insoluble to the salts mentioned above and are particularly suitable for depot treatment of trpanosomal and spirochete diseases. Examples i. 2j, 5.9 3Acety: lamino-q.-oxybenzo, l-i-arsic acid are dissolved in 100 ccm of 2N sodium hydroxide solution. A solution is left with vigorous stirring of 48.5 g of bismuth nitrate in 18.5 g of glycerine and 97 g of water are added dropwise. Then it will be The bismuth salt which has precipitated is neutralized by adding 50 ccm of 2N sodium hydroxide solution sucked off ,. with water, . Alcohol and ether washed and the product in vacuo dried. The preparation is a pale yellowish colored powder.
2. Auf dieselbe Weise, wie in Beispiel i angegeben, lassen sich 25,9 g p-Acetylaminoben:zolarsinsäure in ihr Wisinutsalz überführen.2. In the same way as in Example i, 25.9 g p-Acetylaminoben: convert zolaric acid into its Wisinut salt.
3. 27,29 i-Methy l-2-oxobenzimidazoldihydrid(2, 3)-5-arsinsäure, hergestellt nach der Patentschrift 446 545, wenden in ioo ccm 2 n # N atronlauge gelöst und mit NVismutnitrat, wie in Bespiel i beschrieben, umgegesetzt. Das Wismutsal wird abgesaugt, gewaschen .und getrocknet.3. 27.29 i-Methy l-2-oxobenzimidazole dihydride (2, 3) -5-arsinic acid, prepared according to patent specification 446 545, to be dissolved in 100 ccm of 2 N # sodium hydroxide solution and treated with Nismuth nitrate, as described in example i, implemented. The bismuth salt is suctioned off, washed and dried.
4- 459 der nach Beispiel 2 der Patentschrift 459 362 hergestellten Formal,dehydbisulfitverbindung der 3-Amino-4-oxybenzoli-arsinsäure werden in i50 ccm Wasser gelöst. Unter lebhaftem Rühren läßt man eine nach Beispiel. i hergestellte Lösung von 48,5 g Wismutnitrat zutropfen, neutralisiert dann durch Zugabe von 50 ccm 2n-Natronlauge und trennt .das ausgeschiedene Salz ab, wie in Beispiel i angegeben ist.4-459 of the formal, dehydebisulfite compound of 3-amino-4-oxybenzoliarsinic acid prepared according to example 2 of patent specification 459 362 are dissolved in 150 cc of water. While stirring vigorously, leave one according to the example. I add the prepared solution of 48.5 g of bismuth nitrate dropwise, then neutralize by adding 50 ccm of 2N sodium hydroxide solution and separates the precipitated salt, as indicated in Example i.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEI36185D DE518516C (en) | 1928-11-23 | 1928-11-23 | Process for the preparation of basic bismuth salts of organic arsic acids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEI36185D DE518516C (en) | 1928-11-23 | 1928-11-23 | Process for the preparation of basic bismuth salts of organic arsic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE518516C true DE518516C (en) | 1931-02-17 |
Family
ID=7189177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEI36185D Expired DE518516C (en) | 1928-11-23 | 1928-11-23 | Process for the preparation of basic bismuth salts of organic arsic acids |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE518516C (en) |
-
1928
- 1928-11-23 DE DEI36185D patent/DE518516C/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE518516C (en) | Process for the preparation of basic bismuth salts of organic arsic acids | |
| DE431369C (en) | Manufacture of dye inks | |
| AT154539B (en) | Process for obtaining effective and durable purified extracts from anterior pituitary gland. | |
| DE662035C (en) | Process for the production of laxatives | |
| DE513205C (en) | Process for the preparation of derivatives of the aminoarylantimony compounds | |
| DE715802C (en) | Process for obtaining effective and durable purified extracts from anterior pituitary gland | |
| DE493585C (en) | Production of new alkali-soluble, water-insoluble cellulose derivatives | |
| DE1543966C (en) | Thiamphenicol derivative and process for its preparation | |
| DE862341C (en) | Process for the preparation of aqueous solutions of derivatives of p-aminobenzene sulfonamide | |
| DE431699C (en) | Process for the production of long-life pyrethrum extract emulsions | |
| DE249726C (en) | ||
| DE1129148B (en) | Process for the production of heparin derivatives with cytostatic substances | |
| DE535150C (en) | Process for the production of easily water-soluble, colloidal, complex silver-tannin-protein compounds | |
| DE914541C (en) | Contraceptives | |
| DE862366C (en) | Process for the production of a stable, aqueous, colloidal dispersion of a water-insoluble, alkali-soluble cellulose ether | |
| DE755296C (en) | Process for the production of a protracted preparation of the blood sugar lowering hormone | |
| AT127820B (en) | Process for the preparation of bismuth compounds containing arsenic and antimony. | |
| DE682021C (en) | Process for the preparation of durable complex gold compounds of catechol disulfonic acid | |
| DE942534C (en) | Process for the production of durable and highly effective solutions or suspensions of antibiotic agents | |
| DE522524C (en) | Pest repellant | |
| DE549726C (en) | Process for the preparation of silver, tannin or products containing acyl derivatives and proteins in solid form or in solution | |
| DE723698C (en) | Process for the extraction of water- and lipoid-soluble active ingredients from animal or plant organs | |
| DE662835C (en) | Process for the preparation of water-soluble laxatives | |
| DE561628C (en) | Process for the preparation of a mercury compound of podophyllin | |
| DE948185C (en) | Process for the production of durable water-soluble products from soluble salts of p-naphthionic acid with adrenochrome compounds |